EMVision Medical Devices Equity Raise Less Dilutive Than Anticipated -- Market Talk
Dow Jones
Sep 29, 2025
0051 GMT - EMVision Medical Devices bull Bell Potter raises its target on the stock after a A$12 million equity raising at A$1.94/share. Bell Potter analyst Martyn Jacobs had expected a raising of A$20 million in FY 2026 at A$1.50/share, "so this raising is less dilutionary than expected," he says. The broker's target goes to A$3.15 from A$2.95. It reiterates a buy rating. EMVision is down 1.3% at A$1.915. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)
(END) Dow Jones Newswires
September 28, 2025 20:51 ET (00:51 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.